Utreloxastat

N/A

Report date: 2025/04/20 20:00:03
NME

Base Information

Drug NameUtreloxastat
Drug Alias NamePTC 857PTC-857EPI-857
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 15-lipoxygenase inhibitors
TargetsArachidonate 15-lipoxygenase
Therapy Area/IndicationsNerve DegenerationAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[13
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesPtc Therapeutics Inc
Active IndicationsNerve Degeneration
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A